Trends in tuberculosis clinicians’ adoption of short-course regimens for latent tuberculosis infection

OBJECTIVE: Little is known about regimen choice for latent tuberculosis infection in the United States. Since 2011, the Centers for Disease Control and Prevention has recommended shorter regimens—12 weeks of isoniazid and rifapentine or 4 months of rifampin—because they have similar efficacy, better...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Pei-Jean I., Horne, David J., Wortham, Jonathan M., Katz, Dolly J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320582/
https://www.ncbi.nlm.nih.gov/pubmed/37416302
http://dx.doi.org/10.1016/j.jctube.2023.100382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320582/
https://www.ncbi.nlm.nih.gov/pubmed/37416302
http://dx.doi.org/10.1016/j.jctube.2023.100382

Ejemplares similares